HUP0204176A3 - Recombinant attenuation of prrsv - Google Patents

Recombinant attenuation of prrsv

Info

Publication number
HUP0204176A3
HUP0204176A3 HU0204176A HUP0204176A HUP0204176A3 HU P0204176 A3 HUP0204176 A3 HU P0204176A3 HU 0204176 A HU0204176 A HU 0204176A HU P0204176 A HUP0204176 A HU P0204176A HU P0204176 A3 HUP0204176 A3 HU P0204176A3
Authority
HU
Hungary
Prior art keywords
prrsv
attenuation
recombinant
recombinant attenuation
Prior art date
Application number
HU0204176A
Other languages
Hungarian (hu)
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000103372 external-priority patent/DE10003372A1/en
Priority claimed from DE2000103371 external-priority patent/DE10003371A1/en
Priority claimed from DE2000103373 external-priority patent/DE10003373A1/en
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of HUP0204176A2 publication Critical patent/HUP0204176A2/en
Publication of HUP0204176A3 publication Critical patent/HUP0204176A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
HU0204176A 2000-01-26 2001-01-26 Recombinant attenuation of prrsv HUP0204176A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2000103372 DE10003372A1 (en) 2000-01-26 2000-01-26 Novel live porcine reproductive and respiratory syndrome virus attenuated by mutations in specific site of viral protein coded by specified open reading frames, useful for prophylaxis/treatment of viral infections
DE2000103371 DE10003371A1 (en) 2000-01-26 2000-01-26 Novel live porcine reproductive and respiratory syndrome virus attenuated by mutations in specific site of viral protein coded by specified open reading frames, useful for prophylaxis/treatment of viral infections
DE2000103373 DE10003373A1 (en) 2000-01-26 2000-01-26 Novel live porcine reproductive and respiratory syndrome virus attenuated by mutations in specific site of viral protein coded by specified open reading frames, useful for prophylaxis/treatment of viral infections
PCT/EP2001/000865 WO2001055353A2 (en) 2000-01-26 2001-01-26 Recombinant attenuation of prrsv

Publications (2)

Publication Number Publication Date
HUP0204176A2 HUP0204176A2 (en) 2003-04-28
HUP0204176A3 true HUP0204176A3 (en) 2003-12-29

Family

ID=27213605

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0204176A HUP0204176A3 (en) 2000-01-26 2001-01-26 Recombinant attenuation of prrsv

Country Status (15)

Country Link
EP (1) EP1254213A2 (en)
JP (1) JP2003520601A (en)
KR (1) KR20030032910A (en)
CN (1) CN1406277A (en)
AR (1) AR027291A1 (en)
AU (1) AU2001228502A1 (en)
BR (1) BR0107827A (en)
CA (1) CA2396454A1 (en)
CZ (1) CZ20022554A3 (en)
EA (1) EA200200743A1 (en)
HU (1) HUP0204176A3 (en)
MX (1) MXPA02007198A (en)
PL (1) PL356274A1 (en)
SK (1) SK10932002A3 (en)
WO (1) WO2001055353A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20032743A3 (en) * 2001-03-09 2004-02-18 Boehringer Ingelheim Vetmedica Gmbh Attenuated strains of PRRS virus
US6841364B2 (en) * 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
NZ542902A (en) 2003-03-27 2007-06-29 Ottawa Health Research Inst Mutant vesicular stomatitis viruses and use thereof
MX2007009060A (en) * 2005-02-25 2007-09-11 Pfizer Prod Inc N protein mutants of porcine reproductive and respiratory syndrome virus.
CN100439494C (en) * 2007-03-14 2008-12-03 中国动物疫病预防控制中心 Swine reproduction and respiration syndrome vaccine and its prepn process and application
US7666585B2 (en) 2007-06-15 2010-02-23 Protatek International, Inc. Construction of chimera PRRSV, compositions and vaccine preparations
CN101307305B (en) * 2008-04-30 2010-06-16 中国动物疫病预防控制中心 Low virulent strain of porcine reproductive and respiratory syndrome virus, immunogenicity immunogenicity material and vaccine
UA108902C2 (en) * 2010-11-10 2015-06-25 NORTH AMERICAN REPRODUCTIVE AND RESPIRATORY PIG SYNDROME (PRRS) VIRUS
US10072046B2 (en) * 2014-03-21 2018-09-11 Nutech Ventures Non-naturally occurring porcine reproductive and respiratory syndrome virus (PRRSV) and methods of using

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251397B1 (en) * 1992-10-30 2001-06-26 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same
DE69535061T2 (en) * 1994-08-05 2007-01-25 Regents Of The University Of Minnesota, Minneapolis VIRAL NUCLEOTIDE SEQUENCE VR-2332 AND USE METHOD
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof

Also Published As

Publication number Publication date
SK10932002A3 (en) 2002-11-06
CA2396454A1 (en) 2001-08-02
KR20030032910A (en) 2003-04-26
CN1406277A (en) 2003-03-26
WO2001055353A2 (en) 2001-08-02
EA200200743A1 (en) 2002-12-26
HUP0204176A2 (en) 2003-04-28
AR027291A1 (en) 2003-03-19
JP2003520601A (en) 2003-07-08
CZ20022554A3 (en) 2002-10-16
AU2001228502A1 (en) 2001-08-07
BR0107827A (en) 2002-11-05
WO2001055353A3 (en) 2001-12-27
PL356274A1 (en) 2004-06-28
EP1254213A2 (en) 2002-11-06
MXPA02007198A (en) 2002-12-09

Similar Documents

Publication Publication Date Title
IL138099A0 (en) Bandage
EP1347573A4 (en) Multiplexer
AU8441801A (en) Novel polypeptide
HUP0204176A3 (en) Recombinant attenuation of prrsv
GB0013870D0 (en) Foamed ceramics
GB0015761D0 (en) Polypeptide
ZA200205747B (en) Recombinant attenuation of PRRSV.
GB0120704D0 (en) Polypeptide
HK1046793A1 (en) Multiplexer structure
GB0007525D0 (en) Attenuation Material
EP1354947A4 (en) Novel polypeptide
TW424905U (en) Improved structure of drum-beater
TW541944U (en) Improved structure of ear stick
TW414007U (en) Structure of water-dripping irrigator
TW496608U (en) Structure improvement of row-wire fixing-stage
GB0013239D0 (en) Polypeptide
TW448780U (en) Improved structure of goggles
TW448778U (en) Improved structure of goggles
TW480914U (en) Improved structure of fishpot
TW432952U (en) Improved structure of lunch-box
TW470105U (en) Structure of reinforcement pad block
GB0014085D0 (en) Spot-on
TW487237U (en) Structure of wire-collector for holding-free handset
TW472631U (en) Improved structure of saw
TW457917U (en) Improved structure of teapot